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Abstract
Objective—Healthcare providers (HCPs) are advised to give all parents a strong 
recommendation for HPV vaccination. However, it is possible that strong recommendations could 
be less effective at promoting vaccination among African Americans who on average have greater 
mistrust in the healthcare system. This study examines the associations of parental trust in HCPs 
and strength of HCP vaccination recommendation on HPV vaccine acceptance among African 
American parents.
Methods—Participants were recruited from an urban, academic medical center between July 
2012 and July 2014. We surveyed 400 African American parents of children ages 10 to 12 years 
who were offered HPV vaccine by their HCPs to assess sociodemographic factors, vaccine beliefs, 
trust in HCPs, and the HPV vaccine recommendation received. Medical records were reviewed to 
determine vaccination receipt.
Results—In multivariable analysis, children whose parents were “very strongly” recommended 
the HPV vaccine had over four times higher odds of vaccine receipt compared with those whose 
parents were “not very strongly” recommended the vaccine. Having a parent with “a lot of” versus 
“none” or only “some” trust in HCPs was associated with over twice the odds of receiving HPV 
vaccine. Very strong HCP recommendations were associated with higher odds of vaccination 
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among all subgroups, including those with more negative baseline attitudes toward HPV vaccine 
and those with lower levels of trust. Adding the variables strength of HCP recommendation and 
parental trust in HCPs to a multivariable model already adjusted for sociodemographic factors and 
parental vaccine beliefs improved the pseudo R2 from 0.52 to 0.55.
Conclusions—Among participants, receiving a strong vaccine recommendation and having a 
higher level of trust in HCPs were associated with higher odds of HPV vaccination, but did not 
add much to the predictive value of a model that already adjusted for baseline personal beliefs and 
sociodemographic factors.
Keywords
Human papillomavirus vaccines; African Americans; directive counseling; health knowledge; 
attitudes; practice
Introduction
Racial disparities in cervical cancer morbidity and mortality have persisted over the last 
decade.1 Cervical cancer is diagnosed 30% more frequently in African American women, 
who die nearly twice as frequently of cervical cancer as white women. Given that human 
papillomavirus (HPV) vaccination protects against up to roughly 81% of cases of invasive 
cervical cancer (as well as 74% of all invasive HPV-associated cancers),2-5 achieving a high 
HPV vaccination coverage level could help eliminate cervical cancer health disparities. 
Nonetheless, complete coverage with three vaccine doses in the United States are low among 
all 13-17 year old girls (41.9%) and boys (28.1%) and among African American girls 
(40.8%) and boys (26.0%).6
The Centers for Disease Control and Prevention (CDC) stresses the importance of a strong 
healthcare provider (HCP) recommendation for HPV vaccination with suggested standard 
language to be used in discussions.7 Nonetheless, some studies suggest that vaccination 
counseling should be tailored to each parent's beliefs and perspectives. In two recent studies, 
exposing people to CDC-based information counterintuitively reduced intention to vaccinate 
among those with pre-existing negative attitudes toward vaccination.8,9 Qualitative research 
suggests trust in the HCP promotes parental vaccine acceptance.10-12
Cultural issues affecting health beliefs may be different for African Americans compared 
with Americans of other races. African American parents may have greater concern that 
accepting new vaccines for their children could be exposing them to medical 
experimentation.12-15 In 2007, Washington, DC became one of the first jurisdictions in the 
country to pass an HPV vaccine school mandate (with an opt out clause).16,17 The 
legislation was initially condemned in the Washington Post as a paternalistic mandate 
imposed by white legislators on African American girls and was likened, inaccurately, to the 
Tuskegee syphilis experiment.18 This example illustrates how strong HPV vaccine 
legislation may be perceived as oppressive and discriminatory. It is not clear whether strong 
HPV vaccination recommendations delivered by individual HCPs could also be perceived 
negatively among some African American parents. It is also unclear whether the outcome 
depends on trust in the recommending HCP. The current study examined the dual 
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associations of parental trust in HCPs for vaccine advice and strength of HCP vaccination 
recommendation with HPV vaccine acceptance among African American parents.
Materials and Methods
This study protocol was approved by the Children's National Medical Center Institutional 
Review Board.
Participants and Setting
Between July 2012 to July 2014, 400 participants were recruited from the waiting rooms of 
the pediatric and adolescent health centers within an academic teaching hospital in 
Washington, DC. The health centers report about 40,000 annual encounters from a patient 
population that is 78% African American and 83% publically insured. Participants’ children 
were treated by 26 attending physicians, 4 adolescent medicine fellows, 8 nurse 
practitioners, and 51 pediatric residents (hereafter referred to collectively as HCPs) who 
ordered vaccines and provided all vaccination counseling (i.e., no standing orders). Prior to 
beginning study enrollment, HCPs were informed about the study via email and at one of six 
study information sessions. All HCPs had previously been informed of CDC best practices 
regarding immunization recommendations. In none of the study-specific sessions were 
HCPs instructed to change their practices with respect to recommending immunizations.
Participants were self-identified African American, English-speaking parents or legal 
guardians (hereafter referred to collectively as parents) of children 10-12 years old who had 
not previously received HPV vaccine and were offered the vaccine at that healthcare 
encounter. Age criteria included children recommended for routine receipt of HPV vaccine 
(11-12 years),5 as well as 10 year old children because some HCPs in the practice routinely 
offered HPV vaccine starting at age 10. Parents were excluded if their children had any 
medical contraindications to HPV vaccination.
Survey Administration
Research staff previewed appointment schedules for children meeting age criteria. They 
obtained written informed consent from eligible, interested parents. Study refusers were 
asked for basic demographic information. Upon survey completion, participants were given 
a copy of the HPV Vaccine Information Statement (VIS), the factsheet “Vaccine Safety: The 
Facts” developed by the American Academy of Pediatrics, and a $10 grocery store gift card.
Survey
Items included in the current analysis were part of an orally administered survey designed to 
assess social influences on HPV vaccination decision-making. The survey consisted of two 
parts. Part one was administered prior to the HCP encounter. It assessed sociodemographic 
characteristics (respondent's age, gender, highest educational attainment, history of vaccine 
refusal, whether older children had received HPV vaccine in the past, and child's age, 
gender, and whether the child was overdue for other vaccinations), parental trust in different 
sources of vaccine advice (including “your child's doctors, nurses or other healthcare 
providers,” “websites from doctor groups like the American Academy of Pediatrics,” and 
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“government websites like the Centers for Disease Control and Prevention, also called the 
CDC”), and attitude toward HPV vaccine. Response options for items assessing trust in 
sources of vaccine advice were “not at all,” “some,” and “a lot.” For the item assessing trust 
in HCPs, “not at all” and “some” responses were combined in multivariate analysis due to a 
very low frequency of “not at all” responses.
Items assessing attitude toward HPV vaccination were adapted from a previously validated 
scale of vaccine beliefs.19 The six items were modified slightly to address parental 
respondents and to specify HPV vaccine (e.g., “Vaccines are good for your health” was 
changed to “The HPV vaccine is good for my child's health”). We added a seventh item, 
“African Americans are being targeted for HPV vaccine while it is still somewhat 
experimental” to assess frequency of this potential concern. Response options ascertained 
level of agreement (1= “strongly disagree” to 5= “strongly agree,” with anti-vaccine 
statements reverse coded). A summary pro-vaccine beliefs score was calculated as the mean 
of the seven items’ responses and included in multivariate analysis.
The second part of the survey was administered after the HCP encounter to verify that HPV 
vaccine was offered that day, and to assess each participant's impression of how strongly the 
HCP recommended HPV vaccination (“not very strongly,” “somewhat strongly,” and “very 
strongly”), as well as overall impression of the HCP (1=“worst” and 10=“best”). After the 
encounter, each child's medical record was reviewed to determine prior vaccination status 
and whether HPV vaccine was received that day. We also noted the encounter type (well or 
sick), the healthcare provider's level of training and his/her race.
Statistical Analysis
Only respondents whose children were offered the HPV vaccine that day were included in 
these analyses. All analyses were performed in Stata v13.1.20 Initial bivariate statistics were 
derived using Student's t, Wilcoxon rank-sum, chi-square and Fisher's exact tests. 
Multivariable logistic regression models were created to examine the relationship of the two 
predictor variables of interest, parental trust in the HCP and strength of provider's HPV 
vaccination recommendation, to the outcome, HPV vaccine receipt by the child. Potential 
covariates were checked for collinearity using Pearson correlation coefficients (PCCs), and 
for independence using variable inflation factors (VIFs). Two variables, trust in government 
websites and trust in websites from doctors’ groups for vaccine advice, were highly collinear 
(PCC=0.69), so the variable, trust in websites from doctors’ groups, was dropped. Final 
models included adjustment for parental age and education, child's age and gender, parental 
trust in government websites, parental pro-vaccine beliefs score and encounter type. Models 
treated HCP as a random effect using the xtlogit command. PCC for model variables ranged 
from 0 to |0.39| and all VIFs were <5. Adjusted odds ratios (aOR) with 95% confidence 
intervals (95% CI) were reported for the two variable of interest, strength of HPV vaccine 
recommendation and trust in HCP. To explore the predictive values of these two variables in 
explaining HPV vaccine receipt, increasingly inclusive models were compared for goodness 
of fit using McKelvey & Zavoina's pseudo R2 values. To test for possible modification of the 
effect of strength of provider HPV vaccine recommendation on vaccine receipt by child's 
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gender, parental trust in the HCP and also by parental vaccine beliefs, interaction terms were 
examined.
Results
Of 452 parents initially approached for study participation, 23 did not meet inclusion criteria 
and 29 (6.4%) refused mostly for lack of time. Study refusers were more likely to be men 
(59.0% vs. 24.1%, p <0.1), but were not different from participants in terms of their 
children's genders and ages.
Of the remaining 400 parents included in all analyses, 219 (54.8%) consented for their 
children to receive HPV vaccination that day. Collectively, they were offered the vaccine by 
89 HCPs. Neither the level of training nor race of the HCP was associated with vaccine 
acceptance. Participants were in their late 30s on average and overwhelmingly female (Table 
1). Roughly three-quarters accompanied children who were up-to-date with all other 
recommended vaccinations. Vaccine refusers differed from acceptors in that they were more 
likely to have delayed or refused a vaccine in the past, and were less likely to have consented 
for an older child to receive HPV vaccine in the past. Their children were more likely to be 
female, and less likely to be 11 years old and also less likely to be there for a well child 
encounter that day.
The average pro-vaccine beliefs score for vaccine acceptors was higher than for refusers 
(mean, standard deviation= 3.7, 0.51 vs. 3.0, 0.68, p<.001). Vaccine acceptors were 
significantly more likely to endorse each of the pro-HPV vaccine sentiments and reject each 
of the anti-HPV vaccine sentiments (Table 2). Nonetheless, half of vaccine acceptors did not 
disagree that “African Americans are being targeted for HPV vaccine while it is still 
somewhat experimental,” and 39.7% did not disagree that “If a child gets too many vaccines, 
it can ruin his or her immune system.”
Most participants had at least “some” trust in HCPs for vaccine advice, as well as in 
websites from doctors’ groups from governmental agencies (Table 2). There appeared to be 
a difference in how participants regarded vaccine advice from websites of doctors’ groups 
and governmental agencies as compared with advice received directly from HCPs. While 
trust in websites from doctors’ groups and from governmental agencies were relatively 
highly correlated with each other (PCC= 0.69), neither was highly correlated with trust in 
HCPs (PCC=0.24 and 0.3, respectively). Furthermore, whereas 7.7% of vaccine refusers had 
no trust in doctors’ groups and 13.2% had no trust in government websites, only 1.1% did 
not trust HCPs at all.
Opinions about the HCPs who offered participants’ children the HPV vaccine were 
overwhelmingly positive (Table 3). The median HCP rating by both vaccine acceptors and 
refusers was 10 out of 10. There was a difference between how strongly HPV vaccine 
acceptors and refusers felt the vaccine was recommended to them, with 42.9% of acceptors 
versus only 26.0% of refusers claiming to have received a very strong recommendation (p<.
001). Of those who reported receiving a “very strong” recommendation, 66.7% accepted the 
vaccine, compared with only 56.1% who received a “somewhat strong” recommendation 
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and only 23.8% who received a “not very strong” recommendation. Recommendation 
strength did not interact significantly with child's gender, trust in HCPs for vaccine advice or 
any of the vaccine belief variables in predicting HPV vaccine receipt.
In multivariable analysis, the stronger the HCP recommendation for HPV vaccination, the 
higher the odds of the child receiving it; children whose parents were “very strongly” 
recommended the vaccine had a 4.6 times higher adjusted odds of vaccine receipt compared 
with those whose parents were “not very strongly” recommended the vaccine (Table 4). 
Trust in HCPs for vaccine advice was also associated with HPV vaccine receipt in 
multivariable analysis. Having a parent with “a lot of” versus “none” or only “some” trust in 
HCPs was associated with over twice the adjusted odds of receiving HPV vaccine.
In comparing three incrementally inclusive regression models, we found that the most 
limited model, adjusted only for clustering by HCP and for parental age and education, child 
age and gender, parental trust in government websites, pro-vaccine beliefs score and 
encounter type, had a pseudo R2 of 0.52. Adding the variable strength of HCP's vaccination 
recommendation minimally improved the pseudo R2 to 0.54. Further adding the variable, 
parental trust in HCPs for vaccine advice increased the pseudo R2 slightly to 0.55. Among 
the 80 parents who claimed prior to the healthcare encounter that they preferred their 
children to receive the HPV vaccine at a later date, only 17 (21.2%) ended up changing their 
minds and accepting same-day vaccination after talking with HCPs.
Discussion
Among this sample of African American parents, receiving a stronger vaccine 
recommendation and having more trust in the HCP were associated with greater odds of 
HPV vaccination. However, these two variables did not add much predictive value to a 
model already adjusted for personal vaccination beliefs and sociodemographic factors in 
terms of explaining variance in vaccination decisions.
The literature on optimal strength of HCP recommendation is limited and somewhat 
inconsistent. Two previous studies, which surveyed the same commercial research panel 4 
years apart, found that parents who reported receiving strong HPV recommendations were 
also more likely to self-report their children being vaccinated.21,22 Perhaps conflictingly, 
two other studies found that exposure to strong vaccine advice adapted from CDC's website 
was not associated with increased influenza and measles-mumps-rubella vaccination 
intention, respectively.8,9 In fact, exposing the subgroup of people with more negative 
vaccine beliefs to information debunking anti-vaccine myths actually decreased their 
vaccination intention. We were encouraged to find that among our study population, very 
strong HCP recommendations were associated with higher odds of HPV vaccine uptake 
among all subgroups, including those with more negative baseline attitudes toward HPV 
vaccine. The differences in our results and those of previous studies might suggest that 
parental attitudes toward HPV vaccine may be different from parental attitudes toward other 
vaccines in terms of how strongly they are entrenched and how amenable they are to change. 
Alternatively, the differences may be explained by the fact that virtually all our participants 
trusted their children's HCPs for vaccine advice.
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While 99% of parents trusted their children's HCPs at least some, those who trusted their 
children's HCPs “a lot” had over double the odds of accepting HPV vaccine as compared to 
parents with lower levels of trust. This suggests that HCPs should continually strive to build 
parental trust even after the basic foundation of the parent-provider relationship has been 
established. According to the findings of previous studies, barriers to trust in HCPs for 
African Americans include concerns about financial conflicts of interest, racism and 
experimentation.15,23,24 Suggestions to enhance trust in general include improving African 
Americans’ confidence in HCPs’ cultural, clinical and interpersonal competence.15,23,24 To 
date, no studies have attempted to enhance HCPs’ ability to counsel African American 
parents about HPV vaccine by increasing awareness of and sensitivity to common negative 
vaccine attitudes and beliefs in the African American community. Nevertheless, the benefits 
of culturally tailored health messages is supported by empirical evidence demonstrating 
improved patient outcomes in diabetes and mental health care.25-28 Our findings suggest that 
additional research is warranted to determine culturally informed approaches to building 
parental trust and conveying strong HPV vaccination recommendations to African American 
parents.
Although we found that strength of the HCP's vaccination recommendation and parental 
trust were associated with vaccine acceptance, these two variables explained only a small 
percentage of the total variance in HPV vaccination acceptance. Much more variance was 
explained by parental vaccine beliefs and sociodemographic factors. Similar to two previous 
studies conducted with African American parents,13,14 only roughly half of our participants 
accepted HPV vaccine for their children after it was recommended by the HCP. Thus, HCP 
recommendation may be important, but insufficient to persuade many African American 
parents to vaccinate. In a previous study, African American parents overwhelmingly cited 
doctors as their trusted source of vaccine advice, but also cited other sources including 
friends, media, written materials and the internet.29 Therefore, it may be beneficial to align 
efforts to increase pro-vaccination messages from medical and nonmedical sources and 
broaden interventions beyond simply encouraging HCPs to give strong HPV vaccination 
recommendations.
In a recent randomized controlled trial involving 30 practices in North Carolina, practices 
that received announcement training (i.e., training in how to give brief statements assuming 
parents are ready to vaccinate) had 5.4% larger 6-month increases in first-dose HPV 
vaccination coverage among 11-12 year old children than control practices.30 Based on the 
findings of that study, announcing to a parent that his/her 11 year old child is due for 3 
recommended vaccines that day and placing HPV vaccine in the middle of the list may 
constitute a strong, effective HPV vaccination recommendation for parents in general. 
Further research is needed to determine the effectiveness of using this simple, scripted 
recommendation approach with different subpopulations including parents with baseline 
vaccine hesitancy. Such research could compare the correlation between recommendation 
strength as perceived by the delivering HCP and the receiving parent. This information 
would be helpful for examining whether confirmation bias diminishes the impact of HCP 
recommendations among vaccine hesitant parents. The theory of confirmation bias posits 
that people tend to interpret new information such that it confirms their existing beliefs.31 
Thus, between two parents exposed to the same provider counseling, the parent with a more 
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positive baseline opinion of HPV vaccine may tend to interpret the recommendation to be 
more strongly supportive of vaccination than the parent with more a negative baseline 
opinion of HPV vaccine.
A limitation of our study is that it was conducted in the medical setting to assess health 
beliefs. Thus, although all surveys were conducted in private, responses could have been 
affected by social desirability bias. We also found that trust in HCPs was very high among 
virtually all participants. Thus, our results should not be generalized to populations with 
lower levels of trust in HCPs. In addition, awareness of the purpose of the survey may have 
influenced parental vaccine acceptance or how HCPs recommended vaccination; however, 
we do not think this occurred in any substantial manner since HPV vaccine uptake among 
participants mirrored that of the entire health centers’ population. Further, although we 
examined many variables potentially relevant to parental HPV vaccine decision-making for 
possible inclusion in the multivariable analyses, we cannot account for unmeasured factors. 
Lastly, as with all observational studies, we cannot determine causation only association.
Conclusions
This study supports the notion that HCPs should give African American parents a very 
strong recommendation for HPV vaccine as long as a basic foundation of trust been 
established. This study also finds that strength of vaccine recommendation and trust in HCP 
only explain a small fraction of the variance in HPV vaccine decision-making among 
African American parents suggesting that interventions to improve vaccine uptake should be 
more broadly focused.
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Table 1
Sociodemographic characteristics of participants, their children and their healthcare providers
Characteristic Overall N=400 Acceptors N=219 Refusers N=181 p-value
Respondent's age, mean±SD 37.9±7.7 37.9±7.3 37.9±8.1 0.98
Female respondent, n (%) 374 (93.5) 203 (92.7) 171 (94.5) 0.47
Respondent's educational attainment, n (%)*
    ≤High school graduate 178 (44.7) 104 (47.7) 74 (41.1) 0.23
    Some college/technical school 167 (42.0) 90 (41.3) 77 (42.8)
    College/technical school graduate 53 (13.3) 24 (11.0) 29 (16.1)
Child's age, n (%)*
    10 years 83 (20.8) 22 (10.0) 61 (33.7) <.001
    11 years 209 (52.3) 146 (66.7) 63 (34.8)
    12 years 108 (27.0) 51 (23.3) 57 (31.5)
Female child, n (%) 164 (41.0) 79 (36.1) 85 (47.0) 0.03
Child up-to-date with all other vaccines, n (%) 289 (72.3) 157 (71.7) 132 (72.9) 0.78
Respondent delayed/refused other vaccines in past, n (%)* 34 (8.5) 11 (5.0) 23 (12.7) <.01
Respondent has older children* 198 (49.9) 111 (51.2) 87 (48.3) 0.58
Among respondents with older children, any older child received HPV 
vaccine*
<.001
    No 97 (49.0) 40 (36.0) 57 (65.5)
    Yes 89 (44.9) 64 (57.7) 25 (28.7)
    Don't know 12 (6.1) 7 (6.3) 5 (5.8)
Well encounter* 361 (92.1) 209 (96.8) 152 (86.4) <.001
Healthcare provider training* 0.39
    Attending physician 178 (45.0) 99 (45.4) 79 (44.4)
    Adolescent medicine fellow 30 (7.6) 12 (5.5) 18 (10.1)
    General pediatrics resident 96 (24.2) 54 (24.8) 42 (23.6)
    Nurse practitioner 92 (23.2) 53 (24.3) 39 (21.9)
Healthcare provider race* 0.11
    non-Hispanic White 205 (51.9) 112 (51.6) 93 (52.3)
    African American 88 (22.3) 41 (18.9) 47 (26.4)
    Asian 73 (18.5) 48 (22.1) 25 (14.0)
    Other/Mixed race 29 (7.3) 16 (7.4) 13 (7.3)
*N=392-398 due to missing values
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Table 2
Vaccine beliefs and trust in sources for vaccine advice
Vaccine Acceptors n 
(%) N=219
Vaccine Refusers n (%) 
N=181
p value
Vaccine beliefs
It is important for children to get the HPV vaccine to prevent genital warts 
and cervical cancer.*
<.001
    Agree 194 (88.6) 92 (51.1)
    Do not agree 25 (11.4) 88 (48.9)
The HPV vaccine is good for my child's health.* <.001
    Agree 188 (86.2) 67 (37.0)
    Do not agree 30 (13.8) 114 (63.0)
It is helpful for my child to get the HPV vaccine.* <.001
    Agree 197 (90.0) 63 (35.0)
    Do not agree 22 (10.0) 117 (65.0)
It is safe for a person to get the HPV vaccine. <.001
    Agree 184 (84.0) 77 (42.5)
    Do not agree 35 (16.0) 104 (57.5)
If a child gets too many vaccines, it can ruin his or her immune system. <.001
    Disagree 132 (60.3) 87 (48.1)
    Do not disagree 87 (39.7) 94 (51.9)
The HPV vaccine is dangerous or could cause a bad reaction. <.001
    Disagree 130 (59.4) 54 (29.8)
    Do not disagree 89 (40.6) 127 (70.2)
African Americans are being targeted for HPV vaccine while it is still 
somewhat experimental.
.001
    Disagree 109 (49.8) 61 (33.7)
    Do not disagree 110 (50.2) 120 (66.3)
How much do you trust the following sources for vaccine advice?
Your child's doctors, nurses or other healthcare providers* <.001
    None 1 (0.4) 2 (1.1)
    Some 26 (11.9) 61 (33.9)
    A lot 192 (87.7) 117 (65.0)
Websites from doctor groups like the American Academy of Pediatrics* .30
    None 9 (4.1) 14 (7.7)
    Some 136 (62.4) 111 (61.3)
    A lot 73 (33.5) 56 (31.0)
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Vaccine Acceptors n 
(%) N=219
Vaccine Refusers n (%) 
N=181
p value
Government websites like the Centers for Disease Control and Prevention, 
also called the CDC
.001
    None 7 (3.2) 24 (13.2)
    Some 120 (54.8) 93 (51.4)
    A lot 92 (42.0) 64 (35.4)
*N=399 due to a missing value
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Table 3
Impression of the healthcare provider and his/her vaccination recommendation
Vaccine Acceptors N=219 Vaccine Refusers N=181 p value
Rate the doctor or nurse who offered your child the HPV vaccine. 
(1=worst and 10=best), median [IQR]
10 [9, 10] 10 [9, 10] .1
How strongly did the doctor or nurse recommend your child get the 
HPV vaccine? n (%)
<.001
    Not very strongly 15 (6.9) 48 (26.5)
    Somewhat strongly 110 (50.2) 86 (47.5)
    Very strongly 94 (42.9) 47 (26.0)
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Table 4
Trust in the healthcare provider and strength of his/her vaccination recommendation
Variable OR (95%CI)
aOR* (95%CI)
How much do you trust your child's doctors, nurses or other healthcare providers for vaccine advice?
    None/some ref ref
    A lot 3.6 (2.2, 6.0) 2.3 (1.1, 4.8)
How strongly did the doctor or nurse recommend your child get the HPV vaccine?
    Not very strongly ref ref
    Somewhat strongly 4.2 (2.2, 8.0) 2.5 (1.1, 5.7)
    Very strongly 6.4 (3.3, 12.6) 4.6 (1.9, 11.1)
*Adjusted for clustering by HCP, and for parent's age and education, child's age and gender, visit type, strength of HCP vaccination 
recommendation, trust in HCPs, trust in government websites and vaccine beliefs score
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